Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps

NCT06439381 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinosinusitis

Interventions

DRUG: 300mg/600mg of TQH2722 injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.